Clarius Group LLC Sells 542 Shares of Colgate-Palmolive Company $CL

Clarius Group LLC trimmed its position in Colgate-Palmolive Company (NYSE:CLFree Report) by 12.7% in the second quarter, according to its most recent filing with the SEC. The fund owned 3,741 shares of the company’s stock after selling 542 shares during the period. Clarius Group LLC’s holdings in Colgate-Palmolive were worth $340,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Cornerstone Wealth Management LLC raised its holdings in Colgate-Palmolive by 1.2% in the 1st quarter. Cornerstone Wealth Management LLC now owns 9,035 shares of the company’s stock valued at $847,000 after buying an additional 110 shares during the last quarter. Redhawk Wealth Advisors Inc. raised its stake in shares of Colgate-Palmolive by 2.4% during the second quarter. Redhawk Wealth Advisors Inc. now owns 5,467 shares of the company’s stock valued at $497,000 after acquiring an additional 129 shares during the last quarter. MONECO Advisors LLC lifted its holdings in shares of Colgate-Palmolive by 2.2% during the first quarter. MONECO Advisors LLC now owns 6,051 shares of the company’s stock worth $567,000 after purchasing an additional 133 shares during the period. Ledyard National Bank increased its holdings in Colgate-Palmolive by 4.5% in the first quarter. Ledyard National Bank now owns 3,094 shares of the company’s stock valued at $290,000 after purchasing an additional 134 shares during the period. Finally, Sowell Financial Services LLC lifted its holdings in Colgate-Palmolive by 2.5% during the 2nd quarter. Sowell Financial Services LLC now owns 5,478 shares of the company’s stock worth $498,000 after buying an additional 134 shares during the period. Institutional investors own 80.41% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on CL. Citigroup decreased their target price on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating for the company in a research report on Monday, August 4th. The Goldman Sachs Group lowered their price objective on shares of Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating for the company in a research note on Thursday, October 2nd. UBS Group reduced their target price on Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating for the company in a research note on Thursday, July 17th. Piper Sandler initiated coverage on Colgate-Palmolive in a report on Friday. They issued a “neutral” rating and a $84.00 price target on the stock. Finally, Morgan Stanley decreased their price objective on Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating for the company in a report on Monday, August 4th. Seven equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $94.83.

Read Our Latest Report on Colgate-Palmolive

Colgate-Palmolive Stock Down 0.8%

NYSE:CL opened at $77.39 on Tuesday. The firm has a 50-day simple moving average of $83.11 and a two-hundred day simple moving average of $88.21. The firm has a market cap of $62.55 billion, a P/E ratio of 21.74, a P/E/G ratio of 4.06 and a beta of 0.34. Colgate-Palmolive Company has a fifty-two week low of $77.32 and a fifty-two week high of $102.61. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm had revenue of $5.11 billion for the quarter, compared to analysts’ expectations of $5.03 billion. During the same quarter in the prior year, the company posted $0.91 earnings per share. The business’s revenue for the quarter was up 1.0% on a year-over-year basis. Analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be paid a $0.52 dividend. The ex-dividend date is Friday, October 17th. This represents a $2.08 annualized dividend and a dividend yield of 2.7%. Colgate-Palmolive’s payout ratio is currently 58.43%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.